895 related articles for article (PubMed ID: 2250705)
1. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
Hockenbery D; Nuñez G; Milliman C; Schreiber RD; Korsmeyer SJ
Nature; 1990 Nov; 348(6299):334-6. PubMed ID: 2250705
[TBL] [Abstract][Full Text] [Related]
2. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
Korsmeyer SJ; Shutter JR; Veis DJ; Merry DE; Oltvai ZN
Semin Cancer Biol; 1993 Dec; 4(6):327-32. PubMed ID: 8142617
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2: an antidote to programmed cell death.
Korsmeyer SJ
Cancer Surv; 1992; 15():105-18. PubMed ID: 1451107
[TBL] [Abstract][Full Text] [Related]
5. Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.
Hua C; Zorn S; Jensen JP; Coupland RW; Ko HS; Wright JJ; Bakhshi A
Oncogene Res; 1988 Feb; 2(3):263-75. PubMed ID: 3285301
[TBL] [Abstract][Full Text] [Related]
6. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
[TBL] [Abstract][Full Text] [Related]
7. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
Morelli S; Alama A; Quattrone A; Gong L; Copreni E; Canti G; Nicolin A
Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
[TBL] [Abstract][Full Text] [Related]
9. The bcl-2 oncogene and apoptosis.
Hockenbery DM
Semin Immunol; 1992 Dec; 4(6):413-20. PubMed ID: 1286168
[TBL] [Abstract][Full Text] [Related]
10. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
Nuñez G; London L; Hockenbery D; Alexander M; McKearn JP; Korsmeyer SJ
J Immunol; 1990 May; 144(9):3602-10. PubMed ID: 2184193
[TBL] [Abstract][Full Text] [Related]
11. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene.
Levine B; Huang Q; Isaacs JT; Reed JC; Griffin DE; Hardwick JM
Nature; 1993 Feb; 361(6414):739-42. PubMed ID: 8441470
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.
Aiello A; Delia D; Borrello MG; Biassoni D; Giardini R; Fontanella E; Pezzella F; Pulford K; Pierotti M; Della Porta G
Cytometry; 1992; 13(5):502-9. PubMed ID: 1633729
[TBL] [Abstract][Full Text] [Related]
13. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.
Cotter FE; Johnson P; Hall P; Pocock C; al Mahdi N; Cowell JK; Morgan G
Oncogene; 1994 Oct; 9(10):3049-55. PubMed ID: 8084613
[TBL] [Abstract][Full Text] [Related]
15. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18).
McDonnell TJ; Korsmeyer SJ
Nature; 1991 Jan; 349(6306):254-6. PubMed ID: 1987477
[TBL] [Abstract][Full Text] [Related]
16. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
[TBL] [Abstract][Full Text] [Related]
17. BCL-2 gene family and the regulation of programmed cell death.
Korsmeyer SJ
Cancer Res; 1999 Apr; 59(7 Suppl):1693s-1700s. PubMed ID: 10197582
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
Vaux DL; Cory S; Adams JM
Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
[TBL] [Abstract][Full Text] [Related]
19. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
Heckman CA; Mehew JW; Boxer LM
Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
